DiaMedica Therapeutics
DiaMedica Therapeutics, located in Minneapolis, MN, is dedicated to improving the lives of individuals facing serious vascular diseases through the development of innovative therapies aimed at reducing ischemia. With a primary focus on preeclampsia and acute ischemic stroke, the company strives to enhance patient care by improving blood flow to ischemic tissues to better patient outcomes.
The company's investigational drug candidate, DM199, targets the restoration of KLK1 protein levels, which is crucial for regulating blood flow and maintaining vascular homeostasis. Recognizing the significant unmet needs in both preeclampsia and acute ischemic stroke, DiaMedica is poised to make a meaningful impact in these critical areas of healthcare.
Generated from the website
Also at this address
You might also like
Partial Data by Foursquare.